Nurx is a healthcare technology offering primary care solutions including birth control, HPV testing, PrEP for HIV prevention, and STI testing and treatment.

Buy or sell Nurx stockLearn more about Nurx IPO

OverviewFinancingsValuation

Enterprise Value

Access Nurx’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Nurx.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Edvard Engesaeth MD

Innovation Officer and Co-Founder

Sheena Deol

Executive Assistant

Ted Kraus

Advisor

Jonathan Czaja

Chief Operating Officer

Matthew Dzaman

Head, Engineering

Varsha Rao

Chief Executive Officer

Hans Gangeskar

Co-Founder & Board Member

Michael Hourie

Head of Finance

Board Members

Noah Knauf

Kleiner Perkins

Hans Gangeskar

Chelsea Clinton Ph.D

Clinton Foundation

Regina Benjamin MD

Frequently Asked Questions About Nurx’s Stock

Can you buy Nurx’s stock?

Nurx is not publicly traded on NYSE or NASDAQ in the U.S. To buy Nurx’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Nurx’s stock?

Yes, you can sell stock of a private company like Nurx. Forge can help you sell your Nurx stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Nurx’s stock price?

Nurx is a privately held company and therefore does not have a public stock price. However, you may access Nurx’s private market stock price with Forge Data.

What is Nurx’s stock ticker symbol?

Nurx does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Crunchbase 08/11/2020

Telehealth Startup Nurx Raises $22.5M Series C Extension

Nurx expects to be profitable by early next year.

Techcrunch 03/20/2020

Healthcare startups Nurx and Carbon Health ship at-home COVID-19 test sample kits – TechCrunch

Efforts to get at-home test kits for the COVID-19 coronavirus are ramping up quickly, and two more health industry startups are bringing their own products to market, with both Carbon Health and Nurx starting to ship their own in-home sample collection kits. Both of these new offerings are the same…

Pulse 2.0 08/26/2019

Nurx Receives $52 Million For Expanding Access To Sensitive Health Needs

Nurx, a health tech company that is providing convenient and affordable care for sensitive needs, announced it raised $52 million.

Frequently Asked Questions

Updated on: Apr 25, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Nurx Stock

Register To Buy and Sell Shares